Cite
HARVARD Citation
Tiribelli, M. et al. (2023). Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia. European journal of haematology. pp. 330-331. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tiribelli, M. et al. (2023). Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia. European journal of haematology. pp. 330-331. [Online].